Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat

Journal of Clinical Investigation

Volumn 102, Issue 1, 1998, Pages 202-214

  Vukicevic, Slobodan ^a   Basic, Vanja ^a   Rogic, Dunja ^b   Basic, Nikolina ^a   Shih, Mei Shu ^c   Shepard, Alyssa ^c   Jin, Don ^c   Dattatreyamurty, Bosukonda ^c   Jones, William ^c   Dorai, Haimanti ^c   Ryan, Susan ^c   Griffiths, Denise ^c   Maliakal, James ^c   Jelic, Mislav ^a   Pastorcic, Maria ^a   Stavljenic, Ana ^b   Sampath, T Kuber ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

^c CURIS INC   (United States)

Author keywords

Cytoprotection; Ischemia and reperfusion; Kidney repair and regeneration; Maintenance of vascular smooth muscle cells; Suppression of inflammation; TGF superfamily

Indexed keywords

OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DEATH; CELL PROTECTION; CELL REGENERATION; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; REPERFUSION INJURY;

EID: 0032128140     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2237     Document Type: Article

References (42)

1. Thadhani, R., M. Pascual, and J.V. Bonventre. 1996. Acute renal failure. N. Engl. J. Med. 334:1448-1460.
2. Lieberthal, W., and N.G. Levinsky. 1990. Treatment of acute tubular necrosis. Semin. Nephrol. 10:571-583.
3. Bonventre, J.V. 1993. Mechanisms of ischemic renal failure. Kidney Int. 43:1160-1178.
4. Conger, J.D., M.F. Schultz, F. Miller, and J.B. Robinette. 1994. Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int. 46:318-323.
5. Witzgall, R., D. Brown, C. Schwarz, and J.V. Bonventre. 1994. Localization of proliferating cell number antigen, vimentin, c-Fos and clusterin in the post ischemic kidney: evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and differentiated cells. J. Clin. Invest. 93:2175-2188.
6. Brady, H.R., and G.G. Singer. 1995. Acute renal failure. Lancet. 346: 1533-1540.
7. Racusen, L.C. 1997. Pathology of acute renal failure structure/function correlations. Adv. Ren. Replace. Ther. 4:3-16.
8. Racusen, L.C., B.A. Fivush, Y.-L. Li, I. Slatnick, and K. Solez. 1991. Dissociation of tubular cell detachment and tubular cell death in clinical and experimental "acute tubular necrosis". Lab. Invest. 64:546-556.
9. Humes, H.D. 1995. Acute renal failure: prevailing challenges and prospects for the future. Kidney Int. 48:26-32.
10. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multiple paradigm. Cell. 76:301-314.
11. Klausner, J.M., F.S. Paterson, G. Goldman, L. Kobzik, C. Rodzen, R. Lawrence, C.R. Valeri, D. Shapiro, and H.B. Hechtman. 1989. Postischemic renal injury is mediated by neutrophils and leukotrienes. Am. J. Physiol. 256: F794-F802.
12. Goligorsky, M.S., W. Lieberthal, L. Racusen, and E.E. Simon. 1993. Integrin receptors in renal tubular epithelium: new insights into pathophysiology of acute renal failure. Am. J. Physiol. 264:F1-F8.
13. Kelly, K.J., W.W. Williams, Jr., R.B. Colvin, and J.V. Bonventre. 1994. Intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc. Natl. Acad. Sci. USA. 91:812-816.
14. Conger, J. 1997. Hemodynamic factors in acute renal failure. Adv. Ren. Replace. Ther. 4:25-37.
15. Humes, H.D., and S. Liu. 1994. Cellular and molecular basis of renal repair in acute renal failure. J. Lab. Clin. Med. 124:749-754.
16. Hammerman, M.R., and S.B. Miller. 1994. Therapeutic use of growth factors in renal failure. J. Am. Soc. Nephrol. 5:1-11.
17. Harris, R.C. 1997. Growth factors and cytokines in acute renal failure. Adv. Ren. Replace. Ther. 4:43-53.
18. Humes, H.D., D.A. Cieslinski, T. Coimbra, J.M. Messana, and C. Galvao. 1989. Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J. Clin. Invest. 84:1757-1761.
19. Miller, S.B., D.R. Martin, J. Kissane, and M.R. Hammerman. 1994. Insulin-like growth factor I accelerates recovery from ischemia acute tubular necrosis in the rat. Proc. Natl. Acad. Sci. USA. 89:11876-11880.
20. Miller, S.B., D.R. Martin, J. Kissane, and M.R. Hammerman. 1994. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am. J. Physiol. 266:129-134.
21. Urist, M.R. 1965. Bone: formation by autoinduction. Science. 150:893-899.
22. Sampath, T.K., and A.H. Reddi. 1981. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc. Natl. Acad. Sci. USA. 78:7599-7602.
23. Hogan, B.L.M. 1996. Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev. 6:432-438.
24. Helder, M.N., E. Ozkaynak, T.K. Sampath, F.P. Luyten, V. Latin, H. Oppermann, and S. Vukicevic. 1995. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. J. Histochem. Cytochem. 43:1035-1043.
25. Vukicevic, S., J.B. Kopp, F.P. Luyten, and T.K. Sampath. 1996. Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein-7). Proc. Natl. Acad. Sci. USA. 93:9021-9026.
26. Dudley, A.T., K.M. Lyons, and E.J. Robertson. 1995. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 9:2795-2807.
27. Luo, G., C. Hofmann, A.L.J.J. Bronckers, M. Sohocki, A. Bradley, and G. Karsenty. 1995. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9:2808-2820.
28. Ozkaynak, E., P.N.J. Schnegelsberg, and H. Oppermann. 1991. Murine osteogenic protein-1 (OP-1): high levels of mRNA in kidney. Biochem. Biophys. Res. Commun. 179:116-123.
29. Sampath, T.K., J.C. Maliakal, P.V. Hauschka, W.K. Jones, H. Sasak, R.F. Tucker, K.H. White, J.E. Coughlin, M.M. Tucker, R.H.L. Pang, et al. 1992. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267:20352-20262.
30. Vukicevic, S., V. Latin, P. Chen, R. Batorsky, A.H. Reddi, and T.K. Sampath. 1994. Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity to basement membranes. Biochem. Biophys. Res. Commun. 198:693-700.
31. Bosukonda, D., A. Schneyer, and R.E. Reicher. 1986. Solubilization of functional and stable follitropin receptors from light membranes of bovine calf testis. J. Biol. Chem. 261:13104-13113.
32. Vukicevic, S., A. Stavljenic, T. Boll, M. Cervar, C. Degenhardt, T. Mihaljevic, and B. Krempien. 1989. The influence of early parathyroidectomy on aluminum-induced rickets in growing uremic rats. Bone Miner. 6:125-139.
33. Whelton, A.W., A.J. Watson, and R.C. Rock. 1994. Nitrogen metabolites and renal function. In Clinical Chemistry. C.A. Burtis and E.R. Ashwood, editors. W.B. Saunders, Philadelphia, PA. 1513-1575.
34. Seiberg, M., S. Wisniewski, G. Canwenbergh, and S.S. Shapiro. 1997. Trypsin-induced follicular papilla apoptosis results in delayed hairgrowth and pigmentation. Dev. Dyn. 208:553-564.
35. Shepard, A., J. Maliakal, H. Dorai, D. Jin, N. Basic, H. Opperman, S. Vukicevic, and T.K. Sampath. 1997. OP-1 suppresses ICAM expression in an ARF model as well as in cultured renal cells. J. Am. Soc. Nephrol. 8:2257A.
36. Matejka, G.L., and E. Jennische. 1992 IGF-I binding and IGF-I mRNA expression in the post-ischemic regenerating rat kidney. Kidney Int. 42:1113-1123.
37. Price, P.M., J. Megyesi, S. Saggi, and R.L. Safirstein. 1995. Regulation of transcription by the rat EGF gene promoter in normal and ischemic murine kidney cells. Am. J. Physiol. 268:F664-F670.
38. Lefer, A.M., P.S. Tsao, X.L. Ma, and T.K. Sampath. 1992. Anti-ischemic and endothelial protective actions of recombinant human osteogenic protein-1. J. Mol. Cell. Cardiol. 24:585-543.
39. Perides, G., F.E. Jensen, P. Edgecomb, D.C. Rueger, and M.E. Charness. 1995. Neuroprotective effect of human osteogenic protein-1 in a rat model of cereberal hypoxia/ischemia. Neurosci. Lett. 187:21-24.
40. Chiao, H., Y. Kohda, P. McLeroy, L. Craig, I. Housini, and R. Star. 1997. α-Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 99:1165-1172.
41. Chan, T., S. Falk, and J. Conger. 1997. Effect of osteogenic protein-1 on the course of norepinephrine-induced acute renal failure. J. Am. Soc. Nephrol. 8:2721A.
42. Dorai, H., A. Shepard, J. Maliakal, H. Oppermann, S. Vukicevic, and T.K. Sampath. 1997. Osteogenic protein-1 (OP-1/BMP-7) modulates smooth muscle cell growth and maintains the expression of cell phenotype and protects against cell injury mediated by nephrotoxic and inflammatory agents in vitro. J. Am. Soc. Nephrol. 8:1366A.